OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease
Alessia Carocci, Alexia Barbarossa, Rosalba Leuci, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1631-1631
Open Access | Times Cited: 13

Showing 13 citing articles:

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 34

Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 42

Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults
Francesco Samarelli, Rosa Purgatorio, Gianfranco Lopopolo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116353-116353
Open Access | Times Cited: 8

Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access

Lipoic acid scaffold applications in the design of multitarget-directed ligands against Alzheimer’s disease
Mohammad Amin Manavi, Mona Nourhashemi, Saeed Emami, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108241-108241
Closed Access

Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases
Antonio Carrieri, Alexia Barbarossa, Modesto de Candia, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117829-117829
Open Access | Times Cited: 2

Melatonin and Related Compounds as Antioxidants
Alexia Barbarossa, Antonio Carrieri, Alessia Carocci
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 5, pp. 546-565
Closed Access | Times Cited: 4

Exploring the Pivotal Role of Pyrrolidine Ring in Search of Multipotent Agents in Neurodegenerative Diseases
Antonio Carrieri, Alexia Barbarossa, Modesto de Candia, et al.
(2024)
Closed Access

Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates
Rosalba Leuci, Slobodanka Simic, Antonio Carrieri, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107895-107895
Open Access

Approved Drug Regimens, Combinations, and Delivery Systems for Alzheimer’s Disease
Golamari Siva Reddy, Sreenu Thalla
(2024), pp. 177-198
Closed Access

Therapeutic Options in Alzheimer’s Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1555-1555
Open Access

The Structural Basis of DL0410, a Novel Multi-Target Candidate Drug for the Treatment of Alzheimer’s Disease
Ailin Liu, Jun Zhao, Nicholas J. Huls, et al.
Crystals (2023) Vol. 14, Iss. 1, pp. 59-59
Open Access | Times Cited: 1

Page 1

Scroll to top